Last Verified: | September/30/2019 |
First Submitted: | September/23/2019 |
Estimated Enrollment Submitted: | October/29/2019 |
First Posted: | October/31/2019 |
Last Update Submitted: | October/29/2019 |
Last Update Posted: | October/31/2019 |
Actual Study Start Date: | January/1/2018 |
Estimated Primary Completion Date: | November/30/2019 |
Estimated Study Completion Date: | December/31/2019 |
Study Type: | Interventional |
Allocation: | Randomized |
Primary Purpose: | Prevention |
Masking: | Double (Participant, Care Provider) |
Arm | Intervention/treatment |
---|---|
Active Comparator: dexmedetomidine dexmedetomidine ( precedex) infusion will be administered preoperatively and continued intraoperatively | Drug: dexmedetomidine a loading dose of 1µg/kg of dexmedetomidine (precedex) made to 50 ml using normal saline will be given over 10 minutes followed by infusion of dexmedetomidine with a dose of 0.5µg/kg/hour till the end of surgery. |
Active Comparator: lidocaine Lidocaine (Xylocaine) infusion will be administered preoperatively and continued intraoperatively | Drug: lidocaine a loading dose of 1.5 mg/kg of lidocaine made to 50 ml using normal saline and given over 10 minutes followed by infusion of lidocaine with a dose of 1.5 mg/kg/hour till the end of surgery. |
Placebo Comparator: placebo saline infusion will be administered preoperatively and continued intraoperatively | Drug: placebo 50 ml of normal saline given over 10 minutes followed by saline infusion intraoperatively at a rate of 10 ml/hour till the end of surgery. |
Ages Eligible for Study: | 18 Years to 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria: | Inclusion Criteria: - American society of anesthesia (ASA) Physical Status classification: ASA II physical status. - Age between 18 to 60 years old. - Patients who will undergo major pelviabdominal surgery. Exclusion Criteria: - Patient refusal. - Allergy to local anesthetics. - Cognitive disorders. - uncontrolled diabetes or hypertension. |